Spending on cold and allergy medicines has risen year over year since COVID-19’s onset as well. Since 2019, Americans have spent an additional 23% in the category, totaling $11.8 billion in the last 52 weeks, as of early December.
Stigma surrounding coughs and sneezes and desires to return to normal social activities has led many to spend to mask what is not COVID-19 or flu in order to continue their normal activities, Simon Williams, PhD, a psychologist from Swansea University in Wales, explained to Bloomberg.
Data also shows that fewer adults are taking time off of work for being sick than in previous years.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
